PCIDB

KNApSAcK Metabolite C00001180

Index

Metabolite

Species

Human Protein
/ Gene in interactions

Related Diseases

Metabolite

KNApSAcK Entry

id	C00001180
Name	Butyric acid
CAS RN	107-92-6
Standard InChI	InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)
Standard InChI (Main Layer)	InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)

Cluster

Phytochemical cluster	No. 68
KCF-S cluster	No. 3692

Link

ChEMBL

By standard InChI	CHEMBL14227
By standard InChI Main Layer	CHEMBL14227

KEGG

By LinkDB	C00246

CTD

By CAS RN	D020148

Species

Summary

Plant class

class name	count
rosids	2
asterids	1

Family

family name	count
Vitaceae	1
Brassicaceae	1
Sapotaceae	1

List (3)

* NCBI

KNApSAcK organism	*ID	*family	*plant class	*kingdom
Brassica hirta	3728	Brassicaceae	rosids	Viridiplantae
Sebertia acuminata	280718	Sapotaceae	asterids	Viridiplantae
Vitis vinifera	29760	Vitaceae	rosids	Viridiplantae

Human Protein / Gene in interaction

12 ChEMBL Protein in interactions

accession	description	class description	compound	assay ID (# of activities)	# of diseases (OMIM / KEGG)
Q9HAW8	UDP-glucuronosyltransferase 1-10	Enzyme	CHEMBL14227	CHEMBL1908087 (1)	0 / 0
Q13547	Histone deacetylase 1	Hydrolase	CHEMBL14227	CHEMBL1680132 (1)	0 / 0
Q9BY41	Histone deacetylase 8	Hydrolase	CHEMBL14227	CHEMBL1680135 (1)	2 / 0
Q92769	Histone deacetylase 2	Hydrolase	CHEMBL14227	CHEMBL1680133 (1)	0 / 0
Q9UQL6	Histone deacetylase 5	Hydrolase	CHEMBL14227	CHEMBL1680137 (1)	0 / 0
O15379	Histone deacetylase 3	Hydrolase	CHEMBL14227	CHEMBL1680134 (1)	0 / 0
Q7Z4W1	L-xylulose reductase	Enzyme	CHEMBL14227	CHEMBL706159 (1)	0 / 1
Q9HAW9	UDP-glucuronosyltransferase 1-8	Enzyme	CHEMBL14227	CHEMBL1908085 (1)	0 / 0
P56524	Histone deacetylase 4	Hydrolase	CHEMBL14227	CHEMBL1680136 (1)	1 / 1
Q8WUI4	Histone deacetylase 7	Hydrolase	CHEMBL14227	CHEMBL1680138 (1)	0 / 0
Q9UBN7	Histone deacetylase 6	Hydrolase	CHEMBL14227	CHEMBL1680140 (1) CHEMBL1680141 (1)	0 / 0
Q9UKV0	Histone deacetylase 9	Hydrolase	CHEMBL14227	CHEMBL1680139 (1)	0 / 0

CTD interaction (84)

compound	gene	gene name	gene description	interaction	interaction type	form	reference pmid
D020148	5243	ABCB1 ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1	ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44)	Butyric Acid results in increased expression of ABCB1 mRNA	increases expression	mRNA	15711177
D020148	567	B2M	beta-2-microglobulin	Butyric Acid results in decreased stability of B2M mRNA	decreases stability	mRNA	1693837
D020148	581	BAX BCL2L4	BCL2-associated X protein	Butyric Acid results in increased expression of BAX protein	increases expression	protein	11964082
D020148	6347	CCL2 GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF	chemokine (C-C motif) ligand 2	Butyric Acid results in increased expression of CCL2 mRNA	increases expression	mRNA	17928716
D020148	1026	CDKN1A CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	Butyric Acid results in increased expression of CDKN1A protein	increases expression	protein	15715472
D020148	1026	CDKN1A CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	[Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A mRNA	increases expression	mRNA	21555914
D020148	1026	CDKN1A CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	[Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A protein	increases expression	protein	21555914
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	Butyric Acid results in decreased stability of CGA mRNA	decreases stability	mRNA	1693837
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	Butyric Acid results in increased expression of CGA mRNA	increases expression	mRNA	1693837
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	Butyric Acid results in increased expression of CGA protein	increases expression	protein	1693836 1693837
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	[Theophylline co-treated with Butyric Acid] results in increased expression of CGA mRNA	affects cotreatment / increases expression	mRNA	1693836
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	Theophylline inhibits the reaction [Butyric Acid results in decreased stability of CGA mRNA]	decreases reaction / decreases stability	mRNA	1693837
D020148	1081	CGA CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA	glycoprotein hormones, alpha polypeptide	Theophylline promotes the reaction [Butyric Acid results in increased expression of CGA protein]	increases expression / increases reaction	protein	1693836 1693837
D020148	64581	CLEC7A BGR CANDF4 CLECSF12 DECTIN1	C-type lectin domain family 7, member A	Butyric Acid results in increased expression of CLEC7A mRNA	increases expression	mRNA	15196572
D020148	2002	ELK1	ELK1, member of ETS oncogene family	Butyric Acid results in increased activity of ELK1 protein	increases activity	protein	15103026
D020148	2002	ELK1	ELK1, member of ETS oncogene family	U 0126 inhibits the reaction [Butyric Acid results in increased activity of ELK1 protein]	decreases reaction / increases activity	protein	15103026
D020148	8288	EPX EPO EPP EPX-PEN	eosinophil peroxidase (EC:1.11.1.7)	Butyric Acid results in increased expression of EPX protein	increases expression	protein	14769150
D020148	2100	ESR2 ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2	estrogen receptor 2 (ER beta)	Butyric Acid promotes the reaction [Estradiol results in increased activity of ESR2 protein]	increases activity / increases reaction	protein	15103026
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	Butyric Acid results in increased expression of GATA1 mRNA	increases expression	mRNA	10656287 14757314
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]	decreases reaction / increases expression	mRNA	14769215
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	Quercetin inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	2623	GATA1 ERYF1 GATA-1 GF-1 GF1 NF-E1 NFE1 XLANP XLTDA XLTT	GATA binding protein 1 (globin transcription factor 1)	tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA]	decreases reaction / increases expression	mRNA	14757314
D020148	2624	GATA2 DCML MONOMAC NFE1B	GATA binding protein 2	Butyric Acid results in increased expression of GATA2 mRNA	increases expression	mRNA	14757314
D020148	2624	GATA2 DCML MONOMAC NFE1B	GATA binding protein 2	chebulinic acid promotes the reaction [Butyric Acid results in increased expression of GATA2 mRNA]	increases expression / increases reaction	mRNA	14769215
D020148	2624	GATA2 DCML MONOMAC NFE1B	GATA binding protein 2	tellimagrandin I promotes the reaction [Butyric Acid results in increased expression of GATA2 mRNA]	increases expression / increases reaction	mRNA	14757314
D020148	2993	GYPA CD235a GPA GPErik GPSAT HGpMiV HGpMiXI HGpSta(C) MN MNS PAS-2	glycophorin A (MNS blood group)	Butyric Acid results in increased expression of GYPA protein	increases expression	protein	14757314
D020148	2993	GYPA CD235a GPA GPErik GPSAT HGpMiV HGpMiXI HGpSta(C) MN MNS PAS-2	glycophorin A (MNS blood group)	tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GYPA protein]	decreases reaction / increases expression	protein	14757314
D020148	10013	HDAC6 CPBHM HD6	histone deacetylase 6 (EC:3.5.1.98)	Butyric Acid promotes the reaction [SRSF2 protein binds to HDAC6 protein]	affects binding / increases reaction	protein	21555914
D020148	10013	HDAC6 CPBHM HD6	histone deacetylase 6 (EC:3.5.1.98)	HDAC6 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]	increases expression / increases reaction	protein	21555914
D020148	8290	HIST3H3 H3.4 H3/g H3FT H3t	histone cluster 3, H3	Butyric Acid results in increased acetylation of HIST3H3 protein	increases acetylation	protein	14576182
D020148	121504	HIST4H4 H4/p	histone cluster 4, H4	Butyric Acid results in increased acetylation of HIST4H4 protein	increases acetylation	protein	15103026
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	Butyric Acid results in increased expression of HMBS mRNA	increases expression	mRNA	10656287 14757314
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]	decreases reaction / increases expression	mRNA	14769215
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	Quercetin inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	3145	HMBS PBG-D PBGD PORC UPS	hydroxymethylbilane synthase (EC:2.5.1.61)	tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of HMBS mRNA]	decreases reaction / increases expression	mRNA	14757314
D020148	3606	IL18 IGIF IL-18 IL-1g IL1F4	interleukin 18 (interferon-gamma-inducing factor)	Butyric Acid results in increased expression of IL18 mRNA	increases expression	mRNA	17928716
D020148	3569	IL6 BSF2 HGF HSF IFNB2 IL-6	interleukin 6 (interferon, beta 2)	Butyric Acid results in increased expression of IL6 mRNA	increases expression	mRNA	17928716
D020148	3576	IL8 CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1	interleukin 8	[Butyric Acid co-treated with Glucans] results in increased secretion of IL8 protein	affects cotreatment / increases secretion	protein	15196572
D020148	3576	IL8 CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1	interleukin 8	[Butyric Acid co-treated with Zymosan] results in increased secretion of IL8 protein	affects cotreatment / increases secretion	protein	15196572
D020148	3576	IL8 CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1	interleukin 8	Butyric Acid results in increased expression of IL8 mRNA	increases expression	mRNA	15196572 17928716
D020148	3576	IL8 CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1	interleukin 8	Butyric Acid results in increased secretion of IL8 protein	increases secretion	protein	15196572
D020148	3725	JUN AP-1 AP1 c-Jun	jun proto-oncogene	Butyric Acid results in decreased expression of JUN mRNA	decreases expression	mRNA	9007151
D020148	10524	KAT5 ESA1 HTATIP HTATIP1 PLIP TIP TIP60 ZC2HC5 cPLA2	K(lysine) acetyltransferase 5 (EC:2.3.1.48)	Butyric Acid promotes the reaction [KAT5 protein results in increased acetylation of SRSF2 protein]	increases acetylation / increases reaction	protein	21555914
D020148	10524	KAT5 ESA1 HTATIP HTATIP1 PLIP TIP TIP60 ZC2HC5 cPLA2	K(lysine) acetyltransferase 5 (EC:2.3.1.48)	Butyric Acid promotes the reaction [SRSF2 protein binds to KAT5 protein]	affects binding / increases reaction	protein	21555914
D020148	10524	KAT5 ESA1 HTATIP HTATIP1 PLIP TIP TIP60 ZC2HC5 cPLA2	K(lysine) acetyltransferase 5 (EC:2.3.1.48)	Butyric Acid results in increased expression of KAT5 mRNA	increases expression	mRNA	21555914
D020148	10524	KAT5 ESA1 HTATIP HTATIP1 PLIP TIP TIP60 ZC2HC5 cPLA2	K(lysine) acetyltransferase 5 (EC:2.3.1.48)	Butyric Acid results in increased expression of KAT5 protein	increases expression	protein	21555914
D020148	10524	KAT5 ESA1 HTATIP HTATIP1 PLIP TIP TIP60 ZC2HC5 cPLA2	K(lysine) acetyltransferase 5 (EC:2.3.1.48)	KAT5 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]	increases expression / increases reaction	protein	21555914
D020148	4254	KITLG FPH2 KL-1 Kitl MGF SCF SF SHEP7	KIT ligand	Butyric Acid results in increased expression of KITLG mRNA	increases expression	mRNA	17928716
D020148	4609	MYC MRTL MYCC bHLHe39 c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	Butyric Acid results in decreased expression of MYC mRNA	decreases expression	mRNA	9007151
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	Butyric Acid results in increased expression of NFE2 mRNA	increases expression	mRNA	10656287 14757314
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]	decreases reaction / increases expression	mRNA	14769215
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	Quercetin inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]	decreases reaction / increases expression	mRNA	10656287
D020148	4778	NFE2 NF-E2 p45	nuclear factor, erythroid 2	tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of NFE2 mRNA]	decreases reaction / increases expression	mRNA	14757314
D020148	11315	PARK7 DJ-1 DJ1	parkinson protein 7	Butyric Acid results in increased expression of PARK7 mRNA	increases expression	mRNA	21372141
D020148	11315	PARK7 DJ-1 DJ1	parkinson protein 7	Butyric Acid results in increased expression of PARK7 protein	increases expression	protein	21372141
D020148	5468	PPARG CIMT1 GLM1 NR1C3 PPARG1 PPARG2 PPARgamma	peroxisome proliferator-activated receptor gamma	Butyric Acid results in increased expression of PPARG mRNA	increases expression	mRNA	10833422
D020148	5468	PPARG CIMT1 GLM1 NR1C3 PPARG1 PPARG2 PPARgamma	peroxisome proliferator-activated receptor gamma	Butyric Acid results in increased expression of PPARG protein	increases expression	protein	10833422
D020148	5553	PRG2 BMPG MBP MBP1	proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)	Butyric Acid results in increased expression of PRG2 protein	increases expression	protein	14769150
D020148	5742	PTGS1 COX1 COX3 PCOX1 PES-1 PGG/HS PGHS-1 PGHS1 PHS1 PTGHS	prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)	Butyric Acid results in increased expression of PTGS1 mRNA	increases expression	mRNA	17928716
D020148	5743	PTGS2 COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)	Butyric Acid results in increased expression of PTGS2 mRNA	increases expression	mRNA	17928716
D020148	6647	SOD1 ALS ALS1 IPOA SOD hSod1 homodimer	superoxide dismutase 1, soluble (EC:1.15.1.1)	Butyric Acid affects the activity of SOD1 protein	affects activity	protein	10656287
D020148	6648	SOD2 IPOB MNSOD MVCD6	superoxide dismutase 2, mitochondrial (EC:1.15.1.1)	Butyric Acid results in decreased activity of SOD2 protein	decreases activity	protein	10656287
D020148	6732	SRPK1 SFRSK1	SRSF protein kinase 1 (EC:2.7.11.1)	Butyric Acid affects the localization of SRPK1 protein	affects localization	protein	21555914
D020148	6733	SRPK2 SFRSK2	SRSF protein kinase 2 (EC:2.7.11.1)	Butyric Acid affects the localization of SRPK2 protein	affects localization	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	Butyric Acid promotes the reaction [KAT5 protein results in increased acetylation of SRSF2 protein]	increases acetylation / increases reaction	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	Butyric Acid promotes the reaction [SRSF2 protein binds to HDAC6 protein]	affects binding / increases reaction	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	Butyric Acid promotes the reaction [SRSF2 protein binds to KAT5 protein]	affects binding / increases reaction	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	Butyric Acid results in decreased phosphorylation of SRSF2 protein	decreases phosphorylation	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	Butyric Acid results in increased expression of SRSF2 protein	increases expression	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	[Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A mRNA	increases expression	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	[Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A protein	increases expression	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	HDAC6 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]	increases expression / increases reaction	protein	21555914
D020148	6427	SRSF2 PR264 SC-35 SC35 SFRS2 SFRS2A SRp30b	serine/arginine-rich splicing factor 2	KAT5 protein promotes the reaction [Butyric Acid results in increased expression of SRSF2 protein]	increases expression / increases reaction	protein	21555914
D020148	7040	TGFB1 CED DPD1 LAP TGFB TGFbeta	transforming growth factor, beta 1	Butyric Acid results in increased expression of TGFB1 mRNA	increases expression	mRNA	17928716
D020148	7043	TGFB3 ARVD ARVD1 TGF-beta3	transforming growth factor, beta 3	Butyric Acid results in increased expression of TGFB3 mRNA	increases expression	mRNA	17928716
D020148	7096	TLR1 CD281 TIL TIL._LPRS5 rsc786	toll-like receptor 1	Butyric Acid results in increased expression of TLR1 mRNA	increases expression	mRNA	15196572
D020148	10333	TLR6 CD286	toll-like receptor 6	Butyric Acid results in increased expression of TLR6 mRNA	increases expression	mRNA	15196572
D020148	7124	TNF DIF TNF-alpha TNFA TNFSF2	tumor necrosis factor	Butyric Acid results in increased expression of TNF mRNA	increases expression	mRNA	17928716

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (3)

OMIM	preferred title	UniProt
#600430	Brachydactyly-mental retardation syndrome; bdmr	P56524
#300882	Cornelia de lange syndrome 5; cdls5	Q9BY41
#309585	Wilson-turner x-linked mental retardation syndrome; wts	Q9BY41

KEGG DISEASE (2)

KEGG	disease name	UniProt
H00561	Brachydacytly-mental retardation syndrome and Smith-Magenis syndrome	P56524 (related)
H01065	Pentosuria	Q7Z4W1 (related)

Diseases related to CTD interactions

5 disease from interactions of metabolites

MeSH disease	compound	disease name	evidence type	reference pmid
D000230	D020148	Adenocarcinoma	therapeutic	8298162
D001008	D020148	Anxiety Disorders	marker/mechanism	12431849
D008175	D020148	Lung Neoplasms	therapeutic	8298162
D009139	D020148	Musculoskeletal Abnormalities	marker/mechanism	17517827
D012021	D020148	Reflex, Abnormal	marker/mechanism	12915255

KNApSAcK Metabolite C00001180

Index Metabolite Species Human Protein / Gene in interactions Related Diseases

Metabolite

KNApSAcK Entry

Cluster

Link

ChEMBL

KEGG

CTD

Species

Summary

Plant class

Family

List (3)

* NCBI

Human Protein / Gene in interaction

12 ChEMBL Protein in interactions

CTD interaction (84)

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (3)

KEGG DISEASE (2)

Diseases related to CTD interactions

5 disease from interactions of metabolites

Index

Metabolite

Species

Human Protein
/ Gene in interactions

Related Diseases